Does neoadjuvant androgen deprivation therapy before primary whole gland cryoablation of the prostate affect the outcome?

Urology

Volumn 83, Issue 2, 2014, Pages 379-384

  Grossgold, Erik ^a   Given, Robert ^a   Ruckle, Herbert ^b   Jones, J Stephen ^c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANDROGEN ANTAGONISTS; CRYOSURGERY; DISEASE-FREE SURVIVAL; HUMANS; MALE; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84895071815     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.08.061     Document Type: Article

References (23)

1. M.R. Cooperberg, D.P. Lubeck, and M.V. Meng et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management J Clin Oncol 22 2004 2141 2149
2. J.S. Jones, J.C. Rewcastle, and B.J. Donnelly et al. Whole gland primary prostate cryoablation: initial results from the Cryo On-Line Data registry J Urol 180 2008 554 558
3. C.R. Ritch, and A.E. Katz Prostate cryotherapy: current status Curr Opin Urol 19 2009 177 181
4. J.D. Forman, R. Kumar, and G. Haas et al. Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: effects on the volume of normal tissue irradiation Cancer Invest 13 1995 8 15
5. J.F. Langenhuijsen, E.N. van Lin, and A.L. Hoffmann et al. Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy Urol Oncol 29 2011 52 57
6. A.V. D'Amico, M. Chen, and A.A. Renshaw et al. Androgen suppression and radiation vs radiation alone for prostate cancer JAMA 299 2008 289 295
7. M. Roach, K. Bae, and J. Speight et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610 J Clin Oncol 26 2008 585 591
8. M. Bolla, D. Gonzalez, and P. Warde et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin N Engl J Med 337 1997 295 300
9. M.S. Soloway, K. Pareek, and R. Sharifi et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxM0 prostate cancer: 5-year results J Urol 167 2002 112 116
10. A.V. Bono, F. Pagano, and R. Montironi et al. Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: progress pathology report of the Italian PROSIT study Urology 57 2001 117 121
11. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
12. American Society for Therapeutic Radiation Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1997 1035 1041
13. M.C. Abramowitz, T. Li, and M.K. Buyyounouski et al. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer Cancer 112 2008 55 60
14. C. Huggins, and C.V. Hodges Studies on prostate cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate CA Cancer J Clin 22 1972 232 240
15. F. Schroeder, E.D. Crawford, and A. Axcrona et al. Androgen deprivation therapy: past, present and future BJU Int 109 suppl 6 2012 1 12
16. C.U. Jones, D. Hunt, and D.G. McGowan et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 2011 107 118
17. L. Klotz Active surveillance for low-risk prostate cancer F1000 Med Rep 4 2012 16
18. P. Derakhshani, J. Zumbe, and S. Neubauer et al. Cryoablation of localized prostate cancer: neoadjuvant downsizing of prostate cancer with LH-RH analogue depot before cryosurgery Urol Int 60 suppl 1 1998 2 8
19. D.A. Levy, and J.S. Jones Impact of prostate volume on cryoablation prostate-specific antigen outcomes Urology 77 2011 994 998
20. J.R. Caso, M. Tsivian, and V. Mouraviev et al. Complications and postoperative events after cryosurgery for prostate cancer BJU Int 109 2012 840 845
21. H.K. Tsai, A.V. D'Amico, and N. Sadetsky et al. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality J Natl Cancer Inst 99 2007 1516 1524
22. A.V. D'Amico, J.W. Denham, and J. Crook et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions J Clin Oncol 25 2007 2420 2425
23. H.M. Lakka, D.E. Laaksonen, and T.A. Lakka et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716